...
首页> 外文期刊>Integrative cancer therapies. >Best Case Series Program Supportive Cases of Cordyceps militaris– and Panax notoginseng–Based Anticancer Herbal Formula
【24h】

Best Case Series Program Supportive Cases of Cordyceps militaris– and Panax notoginseng–Based Anticancer Herbal Formula

机译:Case虫草和三七的抗癌草药配方的最佳案例系列计划的辅助案例

获取原文
           

摘要

Objective. The major aim of this study was to present 2 cancer cases treated with anticancer herbal formula Panax notoginseng and Cordyceps militaris. Methods. Two patients, with pancreatic adenocarcinoma and mucosa-associated lymphatic tissue type lymphoma, respectively, were treated with P notoginseng and C militaris herbal formula without conventional treatments. Their tumor masses were compared using computed tomography during early and later periods of herbal formula treatment. Results. On computed tomography, reduction in tumor mass in both patients after 17 and 13 months of herbal treatments was noted, and the patients maintained stable disease and good quality of life until the last contact in November 2008. Conclusion. C militaris and P notoginseng are potential anticancer herbal prescriptions for adenocarcinoma and mucosa-associated lymphatic tissue type lymphoma.
机译:目的。这项研究的主要目的是介绍2例用抗癌草药三七和北冬虫夏草治疗的癌症病例。方法。两名患有胰腺腺癌和粘膜相关淋巴组织型淋巴瘤的患者分别接受三七P和米C草药配方的治疗,无需常规治疗。在草药配方治疗的早期和晚期,使用计算机断层扫描比较了他们的肿瘤质量。结果。在计算机断层扫描上,注意到在用草药治疗17个月和13个月后,这两名患者的肿瘤量均减少了,并且患者保持稳定的疾病和良好的生活质量,直到2008年11月最后一次接触。 C militaris和P三七是针对腺癌和与黏膜相关的淋巴组织型淋巴瘤的潜在抗癌草药处方。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号